In reviewing lab results for a client with multiple myeloma, which value is expected to be elevated?

In multiple myeloma, a type of blood cancer that affects plasma cells, one of the hallmark symptoms is hypercalcemia, which is an elevated level of calcium in the blood. The disease leads to bone lesions and the release of calcium from the bones into the bloodstream, resulting in increased calcium levels. This is a significant clinical finding commonly associated with multiple myeloma and is often considered when diagnosing and managing the condition.

In contrast, while the absolute neutrophil count, platelets, and white blood cells can be affected in various hematological disorders, they do not specifically elevate in relation to multiple myeloma in the same consistent manner. For instance, patients with multiple myeloma may actually experience low levels of certain blood cell counts due to factors like bone marrow infiltration or suppression. Therefore, elevated calcium remains a distinct and expected laboratory finding in clients with multiple myeloma.